Showing 61 - 80 results of 1,754 for search '"Onco"', query time: 0.28s Refine Results
  1. 61
    Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)

    Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC) by Carl Christoph Schimanski, Stefan Kasper, Susanna Hegewisch-Becker, Jan Schröder, Friedrich Overkamp, Frank Kullmann, Wolf Otto Bechstein, Matthias Vöhringer, Robert Öllinger, Florian Lordick, Volker Heinemann, Michael Geißler, Armin Schulz-Abelius, Helga Bernhard, Michael R. Schön, Richard Greil, Peter Galle, Hauke Lang, Irene Schmidtmann, Markus Moehler

    Published 2020-01-01
    “…OncoImmunology…”
    Get full text
    Article
  2. 62
    Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma

    Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma by Christopher Montemagno, Anais Hagege, Delphine Borchiellini, Brice Thamphya, Olivia Rastoin, Damien Ambrosetti, Juan Iovanna, Nathalie Rioux-Leclercq, Camillio Porta, Sylvie Negrier, Jean-Marc Ferrero, Emmanuel Chamorey, Gilles Pagès, Maeva Dufies

    Published 2020-01-01
    “…OncoImmunology…”
    Get full text
    Article
  3. 63
    A representação social do cancro nos estudantes de enfermagem

    A representação social do cancro nos estudantes de enfermagem by Cândida Assunção Santos Pinto, Cristina Freitas Carvalho Sousa Pinto, Olga Maria de Araújo Cunha Rocha, Carla Maria Cerqueira, Inês Maria da Cruz Sousa

    Published 2012-11-01
    “…Onco.News…”
    Get full text
    Article
  4. 64
    Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5+ CD8+ T cell abundance

    Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5+ CD8+ T cell abundance by Qiuren Huang, Quan Zhou, Hongyu Zhang, Zhaopei Liu, Han Zeng, Yifan Chen, Yang Qu, Ying Xiong, Jiajun Wang, Yuan Chang, Yu Xia, Yiwei Wang, Li Liu, Yu Zhu, Le Xu, Bo Dai, Jianming Guo, Zewei Wang, Qi Bai, Weijuan Zhang

    Published 2020-01-01
    “…OncoImmunology…”
    Get full text
    Article
  5. 65
    Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma

    Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma by Vikram S. Pothuri, Graham D. Hogg, Leah Conant, Nicholas Borcherding, C. Alston James, Jacqueline Mudd, Greg Williams, Yongwoo David Seo, William G. Hawkins, Venu G. Pillarisetty, David G. DeNardo, Ryan C. Fields

    Published 2024-12-01
    “…OncoImmunology…”
    Get full text
    Article
  6. 66
    O risco oncológico e a história da saúde na época contemporânea: O caso português no contexto mundial (1889-1939) [parte I]

    O risco oncológico e a história da saúde na época contemporânea: O caso português no contexto mundial (1889-1939) [parte I] by Rui Manuel Pinto Costa

    Published 2011-04-01
    “…Onco.News…”
    Get full text
    Article
  7. 67
    Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition

    Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition by Hans Urban, Laurent M. Willems, Michael W. Ronellenfitsch, Felix Rosenow, Joachim P. Steinbach, Adam Strzelczyk

    Published 2020-01-01
    “…OncoImmunology…”
    Get full text
    Article
  8. 68
    NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML

    NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML by Anne-Sophie Chretien, Raynier Devillier, Cyril Fauriat, Florence Orlanducci, Samia Harbi, Aude Le Roy, Jérôme Rey, Gaelle Bouvier Borg, Emmanuel Gautherot, Jean-François Hamel, Norbert Ifrah, Catherine Lacombe, Pascale Cornillet-Lefebvre, Jacques Delaunay, Antoine Toubert, Christine Arnoulet, Norbert Vey, Didier Blaise, Daniel Olive

    Published 2017-12-01
    “…OncoImmunology…”
    Get full text
    Article
  9. 69
    Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses

    Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses by Ivan Shevchenko, Andreas Mathes, Christopher Groth, Svetlana Karakhanova, Verena Müller, Jochen Utikal, Jens Werner, Alexandr V. Bazhin, Viktor Umansky

    Published 2020-01-01
    “…OncoImmunology…”
    Get full text
    Article
  10. 70
    Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma

    Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma by Ester Simeone, Antonio Maria Grimaldi, Lucia Festino, Diana Giannarelli, Vito Vanella, Marco Palla, Marcello Curvietto, Assunta Esposito, Giuseppe Palmieri, Nicola Mozzillo, Paolo Antonio Ascierto

    Published 2017-03-01
    “…OncoImmunology…”
    Get full text
    Article
  11. 71
    Loss of p27Kip1 leads to expansion of CD4+ effector memory T cells and accelerates colitis-associated colon cancer in mice with a T cell lineage restricted deletion of Smad4

    Loss of p27Kip1 leads to expansion of CD4+ effector memory T cells and accelerates colitis-associated colon cancer in mice with a T cell lineage restricted deletion of Smad4 by Sung Hee Choi, Emily C. Barker, Kyle J. Gerber, John J. Letterio, Byung-Gyu Kim

    Published 2020-01-01
    “…OncoImmunology…”
    Get full text
    Article
  12. 72
    The possibility of cancer immune editing in gliomas. A critical review

    The possibility of cancer immune editing in gliomas. A critical review by Víctor A. Arrieta, Bernardo Cacho-Díaz, Junfei Zhao, Raul Rabadan, Li Chen, Adam M. Sonabend

    Published 2018-07-01
    “…OncoImmunology…”
    Get full text
    Article
  13. 73
    An oncogene regulating chromatin favors response to immunotherapy<subtitle>Oncogene CHAF1A and immunotherapy outcomes</subtitle>

    An oncogene regulating chromatin favors response to immunotherapy<subtitle>Oncogene CHAF1A and immunotherapy outcomes</subtitle> by Leqian Ying, Zhangmin Hu, Yi Lu, Qing Tao, Fen Xiong, Yongqian Shu, Yufei Yang, Xuehan Qiao, Chen Peng, Yuchun Jiang, Miao Han, Min Xu, Xiaoqin Li, Deqiang Wang

    Published 2024-12-01
    “…OncoImmunology…”
    Get full text
    Article
  14. 74
    Significantly different immunological score in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging system

    Significantly different immunological score in lung adenocarcinoma and squamous cell carcinoma and a proposal for a new immune staging system by Ziqing Zeng, Fan Yang, Yunliang Wang, Hua Zhao, Feng Wei, Peng Zhang, Xiying Zhang, Xiubao Ren

    Published 2020-01-01
    “…OncoImmunology…”
    Get full text
    Article
  15. 75
    A transição do homem portador de carcinoma da próstata submetido a prostatectomia radical

    A transição do homem portador de carcinoma da próstata submetido a prostatectomia radical by Jorge Miguel de Sousa Carvalho

    Published 2011-07-01
    “…Onco.News…”
    Get full text
    Article
  16. 76
    A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer

    A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer by Spencer D. Martin, Darin A. Wick, Julie S. Nielsen, Nicole Little, Robert A. Holt, Brad H. Nelson

    Published 2018-01-01
    “…OncoImmunology…”
    Get full text
    Article
  17. 77
    Expression of Tumor-mediated CD137 ligand in human colon cancer indicates dual signaling effects

    Expression of Tumor-mediated CD137 ligand in human colon cancer indicates dual signaling effects by Tanja Grimmig, Martin Gasser, Romana Moench, Lang-Jing Zhu, Karol Nawalaniec, Simone Callies, Martin Wagner, Buelent Polat, Suraj Sarvode Mothi, Yueming Luo, Carmen M. Ribas, Osvaldo Malafaia, Li-Li Hsiao, Ana Maria Waaga-Gasser

    Published 2019-12-01
    “…OncoImmunology…”
    Get full text
    Article
  18. 78
    Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade

    Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade by Rita Greco, Hongjing Qu, Hui Qu, Joachim Theilhaber, Gary Shapiro, Richard Gregory, Christopher Winter, Natalia Malkova, Frank Sun, Julie Jaworski, Annie Best, Lily Pao, Andrew Hebert, Mikhail Levit, Alexei Protopopov, Jack Pollard, Keith Bahjat, Dmitri Wiederschain, Sharad Sharma

    Published 2020-01-01
    “…OncoImmunology…”
    Get full text
    Article
  19. 79
    Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancer

    Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancer by Katsunobu Hagihara, Stephen Chan, Li Zhang, David Y. Oh, Xiao X. Wei, Jeffry Simko, Lawrence Fong

    Published 2019-01-01
    “…OncoImmunology…”
    Get full text
    Article
  20. 80
    Schweinfurthin induces ICD without ER stress and caspase activation

    Schweinfurthin induces ICD without ER stress and caspase activation by Ruoheng Zhang, J.D. Neighbors, T.D. Schell, R.J. Hohl

    Published 2022-12-01
    “…OncoImmunology…”
    Get full text
    Article

Search Tools: